I have played every Silent Hill game," says Ryukishi07, the mythic creator behind the When They Cry visual novels, in ...

Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) had its target price boosted by equities researchers at BMO Capital ...

GlobalData predicts that icotrokinra will reach blockbuster status in 2029, with the drug forecast to generate sales of ...

Protagonist Therapeutics, Inc.'s VERIFY and ANTHEM-UC studies show breakthroughs in polycythemia vera and ulcerative colitis.

Protagonist Therapeutics shares were up 28% to $49.25 after the company reported positive topline results from a Phase 2b study of icotrokinra, conducted by partner Johnson & Johnson.

The protagonist of the new franchise of Naughty Dog will have an element of difference with respect to other games of the ...

Grand Theft Auto VI is more than just another sequel in Rockstar’s legendary franchise—it’s a moment of change in the gaming ...

In a world of high fantasy anime following young, spry adventurers – it's finally time for someone more mature to take the ...

As the Editor of Push Square, Sammy has over 15 years of experience analysing the world of PlayStation, from PS3 through PS5 ...